Companies Dominating the Hypertension Drugs Landscape
- Janssen Global Services, LLC
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Atnahs Pharma UK Limited
- Sanofi US Services Inc.
- Pfizer Laboratories Div Pfizer Inc
- Merck & Co., Inc.
- Abbott Laboratories
- Daiichi Sankyo Company, Limited
- Novartis Pharmaceuticals Corporation
- Boehringer Ingelheim group
- Lupin Ltd.
Browse Key Market Insights with Data Illustration:
In the News
- Janssen Global Services, LLC announced that it has submitted an approval request to the U.S. Food and Drug Administration (FDA) for OPSUMIT (macitentan) for treating adults with inoperable chronic thromboembolic pulmonary hypertension (CTEPH, WHO Group 4)
- AstraZeneca announced that it has completed the divestment agreement of its established hypertension medicines with Atnahs Pharma UK Limited.
